A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus
Clinical trial NCT07599410 · RECRUITING
Trial details
- NCT number
- NCT07599410
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-14
- Primary completion
- 2027-05-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.